Skip to main content

Advertisement

SpringerLink
Log in

Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Background: Treatment satisfaction of patients with primary immunodeficiency diseases receiving hospital-based intravenous (IVIG) or home-based subcutaneous (SCIG) immunoglobulin infusions requires investigation. Objective: Evaluation of the properties and suitability of the Life Quality Index (LQI), as an instrument to assess treatment satisfaction. Methods: Patients received weekly SCIG and completed the LQI, two global treatment satisfaction questions and the CHQ-PF50 (children) or the SF-36 (adults) at baseline and 10 months. The LQI was psychometrically evaluated. Results: The LQI comprised four scales: treatment interference (I), therapy related problems (II), therapy setting (III), treatment costs (IV). Convergent/discriminant validity for scales I, II, III was acceptable, for scale IV moderate. CHQ-PF50 scales behavior, bodily pain, global behavior, global health, mental health, parental impact-emotion significantly correlated with LQI scale II, the family activity scale with LQI scales I, III. SF-36 scale bodily pain significantly correlated with scale III. Internal consistency was good for scales I, II, III, but poor for scale IV. Score values significantly increased for scales I, III, IV in patients switching from IVIG to SCIG. Conclusions: Three valid LQI scales were determined. Cost-related questions should be removed due to low reliability. Patients-perceived therapy effectiveness and patient–physician/nurse interaction should be included in the instrument.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. InstitutionalAuthorNameInternational Union of Immunological Societies (IUIS) Scientific Committee. (1999) ArticleTitlePrimary immun deficiency diseases Clin Exp Immunol. 118 IssueIDSuppl 1 1–28

    Google Scholar 

  2. InstitutionalAuthorNameChapel HM for the Consensus Panel for the Diagnosis management of primary antibody deficiencies (1994) ArticleTitleConsensus on diagnosis and management of primary antibody deficiencies BMJ 308 581–585

    Google Scholar 

  3. MJ. Puck (1997) ArticleTitlePrimary immunodeficiency diseases JAMA 10 1835–1841

    Google Scholar 

  4. RE. Stiehm (1997) ArticleTitleHuman intravenous immunoglobulin in primary and secondary antibody deficiencies Pediatr Infect Dis J 16 696–707 Occurrence Handle9239774

    PubMed  Google Scholar 

  5. PJ Busse S Razvi C. Cunningham-Rundles (2002) ArticleTitleEfficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency J Allergy Clin Immunol 109 1001–1004 Occurrence Handle12063531

    PubMed  Google Scholar 

  6. HW Eijkhout JWM da Meer Particlevan CGM. Kallenberg et al. (2001) ArticleTitleThe effect of two different doses of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypoagammaglobulinemia Ann Intern Med 135 165–174 Occurrence Handle11487483

    PubMed  Google Scholar 

  7. ER Ashida A. Saxon (1986) ArticleTitleHome intravenous immunoglobulin therapy by self-administration J Clin Immunol 6 306–309 Occurrence Handle2427538

    PubMed  Google Scholar 

  8. HD Ochs SH Fischer ML Lee ES Delson HS Kingdon RJ. Wedgwood (1986) ArticleTitleIntravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases Lancet I: 610 IssueID-611 610–611

    Google Scholar 

  9. HD Ochs ML Lee SH Fischer ES Delson BS Chang RJ. Wedgwood (1987) ArticleTitleSelf-infusions of intravenous immunoglobulin by immunodeficient patients at home J Infect Dis 156 652–654 Occurrence Handle3624908

    PubMed  Google Scholar 

  10. RU Soerensen MD Kallick M. Berger (1987) ArticleTitleHome treatment of antibody deficiency syndromes with intravenous immune globulin J Allergy Clin Immunol 80 810–815 Occurrence Handle3693759

    PubMed  Google Scholar 

  11. H Chapel V Brennan E. Delson (1988) ArticleTitleImmunoglobulin replacement therapy by self-infusion at home Clin Exp Immunol 73 160–162 Occurrence Handle3168330

    PubMed  Google Scholar 

  12. RH Kobayashi AD Kobayashi N Lee S Fischer HD. Ochs (1990) ArticleTitleHome self-adminstration of intravenous immunoglobulin therapy in children Pediatr 85 705–709

    Google Scholar 

  13. VM Brennan S Cochrane C Fletcher D Hendy P. Powell (1995) ArticleTitleSurveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at home J Clin Immunol 15 116–119 Occurrence Handle7559908

    PubMed  Google Scholar 

  14. A Gardulf L Hammarström CIE. Smith (1991) ArticleTitleHome treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion Lancet 338 162–166 Occurrence Handle1712881

    PubMed  Google Scholar 

  15. A Gardulf V Andersen J. Björkander et al. (1995) ArticleTitleSubcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs Lancet 345 365–369 Occurrence Handle7845120

    PubMed  Google Scholar 

  16. Abrahamsen TG H Sandersen A. Bustnes (1996) ArticleTitleHome therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies Pediatrics 98 1127–1131 Occurrence Handle8951264

    PubMed  Google Scholar 

  17. J Gaspar B Gerritsen A. Jones (1998) ArticleTitleImmunoglobulin replacement therapy by rapid subcutaneous infusions Arch Dis Child 79 48–51 Occurrence Handle9771252

    PubMed  Google Scholar 

  18. M. Berger (2004) ArticleTitleSubcutaneous immunoglobulin replacement in primary immunodeficiencies Clin Immunol 112 1–7 Occurrence Handle15207776

    PubMed  Google Scholar 

  19. A Gardulf U Nicolay O. Asensio et al. (2004) ArticleTitleChildren and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home J Allergy Clin Immunol 114 936–942 Occurrence Handle15480339

    PubMed  Google Scholar 

  20. MJ Thomas VM Brennan HM. Chapel (1993) ArticleTitleRapid subcutaneous immunoglobulin infusions in children Lancet 342 1432–1433

    Google Scholar 

  21. HM Chapel GP Spickett D. Ericson et al. (2000) ArticleTitleThe comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy J Clin Immunol 20 94–100 Occurrence Handle10821460

    PubMed  Google Scholar 

  22. S Hansen R Gustafson CIE Smith A. Gardulf (2002) ArticleTitleSubcutaneous IgG infusions in patients with primary antibody deficiencies: Decreased time of delivery with maintained safety Clin Immunol 104 237–241 Occurrence Handle12217333

    PubMed  Google Scholar 

  23. M Weaver PD Markson MD Frederick M. Berger (1997) ArticleTitleIssues in the management of treatment satisfaction Am J Manage Care 3 579–594

    Google Scholar 

  24. S Strasser L Aharony D. Greenberger (1993) ArticleTitleThe patient satisfaction process: Moving toward a comprehensive model Med Care Rev. 50 IssueID2 219–248 Occurrence Handle10127084

    PubMed  Google Scholar 

  25. R Shikiar AM. Rentz (2004) ArticleTitleSatisfaction with medication: an overview of conceptual, methodologic, and regulatory issues Value Health 7 204–215 Occurrence Handle15164810

    PubMed  Google Scholar 

  26. J Dunnbar-Jacob JA Erlen EA. Schlenk et al. (2000) ArticleTitleAderence in chronic disease Ann Rev Nurs Res 18 48–90

    Google Scholar 

  27. MJ Atkinson WC Steward JM. Fain et al. (2003) ArticleTitleA new measure of patient satisfaction with ocular hypotensive medications: The treatment satisfaction survey for intraocular pressure (TSS-IOP) Health Quality Life Outcomes. 1 IssueID67 1–13

    Google Scholar 

  28. A Gardulf H Björvell V. Andersen et al. (1995) ArticleTitleLifelong treatment with gammaglobulin for primary antibody deficiencies: The patients’ experiences of subcutaneous self-infusions and home therapy J Adv Nurs 21 917–927 Occurrence Handle7541407

    PubMed  Google Scholar 

  29. PB Daly JH Evans RH. Kobayashi et al. (1991) ArticleTitleHome-based immunoglobulin infusion therapy: Quality of life and patient health perceptions Ann Allergy 67 504–510 Occurrence Handle1958004

    PubMed  Google Scholar 

  30. A Gardulf H Björvell R. Gustafson et al. (1993) ArticleTitleThe life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions Clin Exp Immunol 92 200–204 Occurrence Handle7683584

    PubMed  Google Scholar 

  31. A Gardulf G Möller E. Jonsson (1995) ArticleTitleA comparison of the patient-borne costs of therapy with gamma globulin given at the hospital or at home Int J Technol Asses Health Care 11 345–353

    Google Scholar 

  32. J Landgraf L Abetz JE Ware SuffixJr. (1999) The Child Health Questionnaire (CHQ) A User’s Manual EditionNumber2 The Health Institute Boston

    Google Scholar 

  33. JE Ware KK Snow M. Kosinski (2000) SF-36® Health Survey: Manual and Interpretation Guide QualityMetric Inc. Lincoln, RI

    Google Scholar 

  34. Acquardo C, Jambon B, Ellis D, Marquis P. (1996). Language and translation issues in quality of life and pharmacoeconomics in clinical trials. In: Spilker B. (ed). 2nd ed., 575–586

  35. KN. Lohr (2002) ArticleTitleAssessing health status and quality-of-life instruments: Attributes and review criteria Qual Life Res 11 193–205 Occurrence Handle12074258

    PubMed  Google Scholar 

  36. PM Fayers D. Machin (2000) Quality of Life. Assessment, Analysis and Interpretation John Wiley & Sons Chichester

    Google Scholar 

  37. RA Deyo P Diehr DL. Patrick (1991) ArticleTitleReproducibility and responsiveness of health status measures Contr Clin Trials 12 142S–158S

    Google Scholar 

  38. Fairclough DL. (2002). Design and analysis of quality of life studies in clinical trials. Interdisciplinary Statistics. Chapman & Hall/CRC

  39. MJ Atkinson A Sinha SL. Hass et al. (2004) ArticleTitleValidation of general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease Health Qual Life Outcomes. 2 IssueID12 1–13 Occurrence Handle14713317

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Swedish Center for Immunodeficiencies, Department of Laboratory Medicine, Section of Clinical Immunology, F71, Karolinska Institutet at Karolinska University Hospital, SE-14186, Stockholm, Sweden

    U. Nicolay & A. Gardulf

  2. ZLB Behring, Marburg, Germany

    S. Haag & S. Herget

  3. Kendle International Inc., Munich, Germany

    F. Eichmann

  4. Department of Biostatistics, Accovion GmbH, Marburg, Germany

    D. Spruck

Authors
  1. U. Nicolay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Haag
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Eichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Herget
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Spruck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Gardulf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Nicolay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicolay, U., Haag, S., Eichmann, F. et al. Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy. Qual Life Res 14, 1683–1691 (2005). https://doi.org/10.1007/s11136-005-1746-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-005-1746-x

Keywords

Search

Navigation